Global Notoginsenoside Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global DSA Imaging Operating Bed market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
As vascular interventional surgery continues to become more popular, the demand for DSA imaging operating beds is also increasing. The DSA imaging operating bed can provide high-definition angiography images to help doctors diagnose and formulate surgical plans more accurately, thereby improving the accuracy and safety of surgery. In the future, with the widespread application of vascular interventional surgeries, the market demand for DSA imaging operating beds will continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “DSA Imaging Operating Bed Industry Forecast” looks at past sales and reviews total world DSA Imaging Operating Bed sales in 2024, providing a comprehensive analysis by region and market sector of projected DSA Imaging Operating Bed sales for 2025 through 2031. With DSA Imaging Operating Bed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DSA Imaging Operating Bed industry.
This Insight Report provides a comprehensive analysis of the global DSA Imaging Operating Bed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DSA Imaging Operating Bed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DSA Imaging Operating Bed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DSA Imaging Operating Bed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DSA Imaging Operating Bed.
This report presents a comprehensive overview, market shares, and growth opportunities of DSA Imaging Operating Bed market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global DSA Imaging Operating Bed market?
What factors are driving DSA Imaging Operating Bed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DSA Imaging Operating Bed market opportunities vary by end market size?
How does DSA Imaging Operating Bed break out by Type, by Application?
The global DSA Imaging Operating Bed market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
As vascular interventional surgery continues to become more popular, the demand for DSA imaging operating beds is also increasing. The DSA imaging operating bed can provide high-definition angiography images to help doctors diagnose and formulate surgical plans more accurately, thereby improving the accuracy and safety of surgery. In the future, with the widespread application of vascular interventional surgeries, the market demand for DSA imaging operating beds will continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “DSA Imaging Operating Bed Industry Forecast” looks at past sales and reviews total world DSA Imaging Operating Bed sales in 2024, providing a comprehensive analysis by region and market sector of projected DSA Imaging Operating Bed sales for 2025 through 2031. With DSA Imaging Operating Bed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DSA Imaging Operating Bed industry.
This Insight Report provides a comprehensive analysis of the global DSA Imaging Operating Bed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DSA Imaging Operating Bed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DSA Imaging Operating Bed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DSA Imaging Operating Bed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DSA Imaging Operating Bed.
This report presents a comprehensive overview, market shares, and growth opportunities of DSA Imaging Operating Bed market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Flat-Panel DSA Angiography Operating Table
- Suspended DSA Angiography Operating Table
- Operating Room
- ICU
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AADCO Medical
- ALVO Medical
- BIODEX
- Infimed
- Infinium
- Mizuho OSI
- Medifa
- Schaerer
- Allengers
- Ima-x
What is the 10-year outlook for the global DSA Imaging Operating Bed market?
What factors are driving DSA Imaging Operating Bed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DSA Imaging Operating Bed market opportunities vary by end market size?
How does DSA Imaging Operating Bed break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Notoginsenoside Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Notoginsenoside by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Notoginsenoside by Country/Region, 2020, 2024 & 2031
2.2 Notoginsenoside Segment by Type
2.2.1 Notoginsenoside R1
2.2.2 Notoginsenoside R2
2.3 Notoginsenoside Sales by Type
2.3.1 Global Notoginsenoside Sales Market Share by Type (2020-2025)
2.3.2 Global Notoginsenoside Revenue and Market Share by Type (2020-2025)
2.3.3 Global Notoginsenoside Sale Price by Type (2020-2025)
2.4 Notoginsenoside Segment by Application
2.4.1 Medicines
2.4.2 Health Products
2.4.3 Others
2.5 Notoginsenoside Sales by Application
2.5.1 Global Notoginsenoside Sale Market Share by Application (2020-2025)
2.5.2 Global Notoginsenoside Revenue and Market Share by Application (2020-2025)
2.5.3 Global Notoginsenoside Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Notoginsenoside Breakdown Data by Company
3.1.1 Global Notoginsenoside Annual Sales by Company (2020-2025)
3.1.2 Global Notoginsenoside Sales Market Share by Company (2020-2025)
3.2 Global Notoginsenoside Annual Revenue by Company (2020-2025)
3.2.1 Global Notoginsenoside Revenue by Company (2020-2025)
3.2.2 Global Notoginsenoside Revenue Market Share by Company (2020-2025)
3.3 Global Notoginsenoside Sale Price by Company
3.4 Key Manufacturers Notoginsenoside Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Notoginsenoside Product Location Distribution
3.4.2 Players Notoginsenoside Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NOTOGINSENOSIDE BY GEOGRAPHIC REGION
4.1 World Historic Notoginsenoside Market Size by Geographic Region (2020-2025)
4.1.1 Global Notoginsenoside Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Notoginsenoside Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Notoginsenoside Market Size by Country/Region (2020-2025)
4.2.1 Global Notoginsenoside Annual Sales by Country/Region (2020-2025)
4.2.2 Global Notoginsenoside Annual Revenue by Country/Region (2020-2025)
4.3 Americas Notoginsenoside Sales Growth
4.4 APAC Notoginsenoside Sales Growth
4.5 Europe Notoginsenoside Sales Growth
4.6 Middle East & Africa Notoginsenoside Sales Growth
5 AMERICAS
5.1 Americas Notoginsenoside Sales by Country
5.1.1 Americas Notoginsenoside Sales by Country (2020-2025)
5.1.2 Americas Notoginsenoside Revenue by Country (2020-2025)
5.2 Americas Notoginsenoside Sales by Type (2020-2025)
5.3 Americas Notoginsenoside Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Notoginsenoside Sales by Region
6.1.1 APAC Notoginsenoside Sales by Region (2020-2025)
6.1.2 APAC Notoginsenoside Revenue by Region (2020-2025)
6.2 APAC Notoginsenoside Sales by Type (2020-2025)
6.3 APAC Notoginsenoside Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Notoginsenoside by Country
7.1.1 Europe Notoginsenoside Sales by Country (2020-2025)
7.1.2 Europe Notoginsenoside Revenue by Country (2020-2025)
7.2 Europe Notoginsenoside Sales by Type (2020-2025)
7.3 Europe Notoginsenoside Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Notoginsenoside by Country
8.1.1 Middle East & Africa Notoginsenoside Sales by Country (2020-2025)
8.1.2 Middle East & Africa Notoginsenoside Revenue by Country (2020-2025)
8.2 Middle East & Africa Notoginsenoside Sales by Type (2020-2025)
8.3 Middle East & Africa Notoginsenoside Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Notoginsenoside
10.3 Manufacturing Process Analysis of Notoginsenoside
10.4 Industry Chain Structure of Notoginsenoside
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Notoginsenoside Distributors
11.3 Notoginsenoside Customer
12 WORLD FORECAST REVIEW FOR NOTOGINSENOSIDE BY GEOGRAPHIC REGION
12.1 Global Notoginsenoside Market Size Forecast by Region
12.1.1 Global Notoginsenoside Forecast by Region (2026-2031)
12.1.2 Global Notoginsenoside Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Notoginsenoside Forecast by Type (2026-2031)
12.7 Global Notoginsenoside Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ChemFaces
13.1.1 ChemFaces Company Information
13.1.2 ChemFaces Notoginsenoside Product Portfolios and Specifications
13.1.3 ChemFaces Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ChemFaces Main Business Overview
13.1.5 ChemFaces Latest Developments
13.2 Merck Group
13.2.1 Merck Group Company Information
13.2.2 Merck Group Notoginsenoside Product Portfolios and Specifications
13.2.3 Merck Group Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Group Main Business Overview
13.2.5 Merck Group Latest Developments
13.3 BioCrick
13.3.1 BioCrick Company Information
13.3.2 BioCrick Notoginsenoside Product Portfolios and Specifications
13.3.3 BioCrick Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BioCrick Main Business Overview
13.3.5 BioCrick Latest Developments
13.4 Yunnan Baiyao Group
13.4.1 Yunnan Baiyao Group Company Information
13.4.2 Yunnan Baiyao Group Notoginsenoside Product Portfolios and Specifications
13.4.3 Yunnan Baiyao Group Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yunnan Baiyao Group Main Business Overview
13.4.5 Yunnan Baiyao Group Latest Developments
13.5 Xi'an Tianbao Biotechnology Co., Ltd.
13.5.1 Xi'an Tianbao Biotechnology Co., Ltd. Company Information
13.5.2 Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.5.3 Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Xi'an Tianbao Biotechnology Co., Ltd. Main Business Overview
13.5.5 Xi'an Tianbao Biotechnology Co., Ltd. Latest Developments
13.6 Xi'an Zebang Biotechnology Co., Ltd.
13.6.1 Xi'an Zebang Biotechnology Co., Ltd. Company Information
13.6.2 Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.6.3 Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Xi'an Zebang Biotechnology Co., Ltd. Main Business Overview
13.6.5 Xi'an Zebang Biotechnology Co., Ltd. Latest Developments
13.7 Shanghai yuanye Bio-Technology Co., Ltd
13.7.1 Shanghai yuanye Bio-Technology Co., Ltd Company Information
13.7.2 Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Product Portfolios and Specifications
13.7.3 Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai yuanye Bio-Technology Co., Ltd Main Business Overview
13.7.5 Shanghai yuanye Bio-Technology Co., Ltd Latest Developments
13.8 Chengdu Chaojiuba Biotechnology Co., Ltd.
13.8.1 Chengdu Chaojiuba Biotechnology Co., Ltd. Company Information
13.8.2 Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.8.3 Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Chengdu Chaojiuba Biotechnology Co., Ltd. Main Business Overview
13.8.5 Chengdu Chaojiuba Biotechnology Co., Ltd. Latest Developments
13.9 Nanjing Tianrun Biotechnology Co., Ltd.
13.9.1 Nanjing Tianrun Biotechnology Co., Ltd. Company Information
13.9.2 Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.9.3 Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nanjing Tianrun Biotechnology Co., Ltd. Main Business Overview
13.9.5 Nanjing Tianrun Biotechnology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Notoginsenoside Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Notoginsenoside by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Notoginsenoside by Country/Region, 2020, 2024 & 2031
2.2 Notoginsenoside Segment by Type
2.2.1 Notoginsenoside R1
2.2.2 Notoginsenoside R2
2.3 Notoginsenoside Sales by Type
2.3.1 Global Notoginsenoside Sales Market Share by Type (2020-2025)
2.3.2 Global Notoginsenoside Revenue and Market Share by Type (2020-2025)
2.3.3 Global Notoginsenoside Sale Price by Type (2020-2025)
2.4 Notoginsenoside Segment by Application
2.4.1 Medicines
2.4.2 Health Products
2.4.3 Others
2.5 Notoginsenoside Sales by Application
2.5.1 Global Notoginsenoside Sale Market Share by Application (2020-2025)
2.5.2 Global Notoginsenoside Revenue and Market Share by Application (2020-2025)
2.5.3 Global Notoginsenoside Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Notoginsenoside Breakdown Data by Company
3.1.1 Global Notoginsenoside Annual Sales by Company (2020-2025)
3.1.2 Global Notoginsenoside Sales Market Share by Company (2020-2025)
3.2 Global Notoginsenoside Annual Revenue by Company (2020-2025)
3.2.1 Global Notoginsenoside Revenue by Company (2020-2025)
3.2.2 Global Notoginsenoside Revenue Market Share by Company (2020-2025)
3.3 Global Notoginsenoside Sale Price by Company
3.4 Key Manufacturers Notoginsenoside Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Notoginsenoside Product Location Distribution
3.4.2 Players Notoginsenoside Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NOTOGINSENOSIDE BY GEOGRAPHIC REGION
4.1 World Historic Notoginsenoside Market Size by Geographic Region (2020-2025)
4.1.1 Global Notoginsenoside Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Notoginsenoside Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Notoginsenoside Market Size by Country/Region (2020-2025)
4.2.1 Global Notoginsenoside Annual Sales by Country/Region (2020-2025)
4.2.2 Global Notoginsenoside Annual Revenue by Country/Region (2020-2025)
4.3 Americas Notoginsenoside Sales Growth
4.4 APAC Notoginsenoside Sales Growth
4.5 Europe Notoginsenoside Sales Growth
4.6 Middle East & Africa Notoginsenoside Sales Growth
5 AMERICAS
5.1 Americas Notoginsenoside Sales by Country
5.1.1 Americas Notoginsenoside Sales by Country (2020-2025)
5.1.2 Americas Notoginsenoside Revenue by Country (2020-2025)
5.2 Americas Notoginsenoside Sales by Type (2020-2025)
5.3 Americas Notoginsenoside Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Notoginsenoside Sales by Region
6.1.1 APAC Notoginsenoside Sales by Region (2020-2025)
6.1.2 APAC Notoginsenoside Revenue by Region (2020-2025)
6.2 APAC Notoginsenoside Sales by Type (2020-2025)
6.3 APAC Notoginsenoside Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Notoginsenoside by Country
7.1.1 Europe Notoginsenoside Sales by Country (2020-2025)
7.1.2 Europe Notoginsenoside Revenue by Country (2020-2025)
7.2 Europe Notoginsenoside Sales by Type (2020-2025)
7.3 Europe Notoginsenoside Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Notoginsenoside by Country
8.1.1 Middle East & Africa Notoginsenoside Sales by Country (2020-2025)
8.1.2 Middle East & Africa Notoginsenoside Revenue by Country (2020-2025)
8.2 Middle East & Africa Notoginsenoside Sales by Type (2020-2025)
8.3 Middle East & Africa Notoginsenoside Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Notoginsenoside
10.3 Manufacturing Process Analysis of Notoginsenoside
10.4 Industry Chain Structure of Notoginsenoside
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Notoginsenoside Distributors
11.3 Notoginsenoside Customer
12 WORLD FORECAST REVIEW FOR NOTOGINSENOSIDE BY GEOGRAPHIC REGION
12.1 Global Notoginsenoside Market Size Forecast by Region
12.1.1 Global Notoginsenoside Forecast by Region (2026-2031)
12.1.2 Global Notoginsenoside Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Notoginsenoside Forecast by Type (2026-2031)
12.7 Global Notoginsenoside Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ChemFaces
13.1.1 ChemFaces Company Information
13.1.2 ChemFaces Notoginsenoside Product Portfolios and Specifications
13.1.3 ChemFaces Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ChemFaces Main Business Overview
13.1.5 ChemFaces Latest Developments
13.2 Merck Group
13.2.1 Merck Group Company Information
13.2.2 Merck Group Notoginsenoside Product Portfolios and Specifications
13.2.3 Merck Group Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Group Main Business Overview
13.2.5 Merck Group Latest Developments
13.3 BioCrick
13.3.1 BioCrick Company Information
13.3.2 BioCrick Notoginsenoside Product Portfolios and Specifications
13.3.3 BioCrick Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BioCrick Main Business Overview
13.3.5 BioCrick Latest Developments
13.4 Yunnan Baiyao Group
13.4.1 Yunnan Baiyao Group Company Information
13.4.2 Yunnan Baiyao Group Notoginsenoside Product Portfolios and Specifications
13.4.3 Yunnan Baiyao Group Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yunnan Baiyao Group Main Business Overview
13.4.5 Yunnan Baiyao Group Latest Developments
13.5 Xi'an Tianbao Biotechnology Co., Ltd.
13.5.1 Xi'an Tianbao Biotechnology Co., Ltd. Company Information
13.5.2 Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.5.3 Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Xi'an Tianbao Biotechnology Co., Ltd. Main Business Overview
13.5.5 Xi'an Tianbao Biotechnology Co., Ltd. Latest Developments
13.6 Xi'an Zebang Biotechnology Co., Ltd.
13.6.1 Xi'an Zebang Biotechnology Co., Ltd. Company Information
13.6.2 Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.6.3 Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Xi'an Zebang Biotechnology Co., Ltd. Main Business Overview
13.6.5 Xi'an Zebang Biotechnology Co., Ltd. Latest Developments
13.7 Shanghai yuanye Bio-Technology Co., Ltd
13.7.1 Shanghai yuanye Bio-Technology Co., Ltd Company Information
13.7.2 Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Product Portfolios and Specifications
13.7.3 Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai yuanye Bio-Technology Co., Ltd Main Business Overview
13.7.5 Shanghai yuanye Bio-Technology Co., Ltd Latest Developments
13.8 Chengdu Chaojiuba Biotechnology Co., Ltd.
13.8.1 Chengdu Chaojiuba Biotechnology Co., Ltd. Company Information
13.8.2 Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.8.3 Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Chengdu Chaojiuba Biotechnology Co., Ltd. Main Business Overview
13.8.5 Chengdu Chaojiuba Biotechnology Co., Ltd. Latest Developments
13.9 Nanjing Tianrun Biotechnology Co., Ltd.
13.9.1 Nanjing Tianrun Biotechnology Co., Ltd. Company Information
13.9.2 Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
13.9.3 Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nanjing Tianrun Biotechnology Co., Ltd. Main Business Overview
13.9.5 Nanjing Tianrun Biotechnology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Notoginsenoside Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Notoginsenoside Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Notoginsenoside R1
Table 4. Major Players of Notoginsenoside R2
Table 5. Global Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 6. Global Notoginsenoside Sales Market Share by Type (2020-2025)
Table 7. Global Notoginsenoside Revenue by Type (2020-2025) & ($ million)
Table 8. Global Notoginsenoside Revenue Market Share by Type (2020-2025)
Table 9. Global Notoginsenoside Sale Price by Type (2020-2025) & (US$/g)
Table 10. Global Notoginsenoside Sale by Application (2020-2025) & (kg)
Table 11. Global Notoginsenoside Sale Market Share by Application (2020-2025)
Table 12. Global Notoginsenoside Revenue by Application (2020-2025) & ($ million)
Table 13. Global Notoginsenoside Revenue Market Share by Application (2020-2025)
Table 14. Global Notoginsenoside Sale Price by Application (2020-2025) & (US$/g)
Table 15. Global Notoginsenoside Sales by Company (2020-2025) & (kg)
Table 16. Global Notoginsenoside Sales Market Share by Company (2020-2025)
Table 17. Global Notoginsenoside Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Notoginsenoside Revenue Market Share by Company (2020-2025)
Table 19. Global Notoginsenoside Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key Manufacturers Notoginsenoside Producing Area Distribution and Sales Area
Table 21. Players Notoginsenoside Products Offered
Table 22. Notoginsenoside Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Notoginsenoside Sales by Geographic Region (2020-2025) & (kg)
Table 26. Global Notoginsenoside Sales Market Share Geographic Region (2020-2025)
Table 27. Global Notoginsenoside Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Notoginsenoside Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Notoginsenoside Sales by Country/Region (2020-2025) & (kg)
Table 30. Global Notoginsenoside Sales Market Share by Country/Region (2020-2025)
Table 31. Global Notoginsenoside Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Notoginsenoside Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 34. Americas Notoginsenoside Sales Market Share by Country (2020-2025)
Table 35. Americas Notoginsenoside Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 37. Americas Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 38. APAC Notoginsenoside Sales by Region (2020-2025) & (kg)
Table 39. APAC Notoginsenoside Sales Market Share by Region (2020-2025)
Table 40. APAC Notoginsenoside Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 42. APAC Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 43. Europe Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 44. Europe Notoginsenoside Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 46. Europe Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 47. Middle East & Africa Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 48. Middle East & Africa Notoginsenoside Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 50. Middle East & Africa Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Notoginsenoside
Table 52. Key Market Challenges & Risks of Notoginsenoside
Table 53. Key Industry Trends of Notoginsenoside
Table 54. Notoginsenoside Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Notoginsenoside Distributors List
Table 57. Notoginsenoside Customer List
Table 58. Global Notoginsenoside Sales Forecast by Region (2026-2031) & (kg)
Table 59. Global Notoginsenoside Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 61. Americas Notoginsenoside Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Notoginsenoside Sales Forecast by Region (2026-2031) & (kg)
Table 63. APAC Notoginsenoside Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 65. Europe Notoginsenoside Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 67. Middle East & Africa Notoginsenoside Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Notoginsenoside Sales Forecast by Type (2026-2031) & (kg)
Table 69. Global Notoginsenoside Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Notoginsenoside Sales Forecast by Application (2026-2031) & (kg)
Table 71. Global Notoginsenoside Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. ChemFaces Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 73. ChemFaces Notoginsenoside Product Portfolios and Specifications
Table 74. ChemFaces Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. ChemFaces Main Business
Table 76. ChemFaces Latest Developments
Table 77. Merck Group Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Group Notoginsenoside Product Portfolios and Specifications
Table 79. Merck Group Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. Merck Group Main Business
Table 81. Merck Group Latest Developments
Table 82. BioCrick Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 83. BioCrick Notoginsenoside Product Portfolios and Specifications
Table 84. BioCrick Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. BioCrick Main Business
Table 86. BioCrick Latest Developments
Table 87. Yunnan Baiyao Group Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 88. Yunnan Baiyao Group Notoginsenoside Product Portfolios and Specifications
Table 89. Yunnan Baiyao Group Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Yunnan Baiyao Group Main Business
Table 91. Yunnan Baiyao Group Latest Developments
Table 92. Xi'an Tianbao Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 93. Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 94. Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 95. Xi'an Tianbao Biotechnology Co., Ltd. Main Business
Table 96. Xi'an Tianbao Biotechnology Co., Ltd. Latest Developments
Table 97. Xi'an Zebang Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 98. Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 99. Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 100. Xi'an Zebang Biotechnology Co., Ltd. Main Business
Table 101. Xi'an Zebang Biotechnology Co., Ltd. Latest Developments
Table 102. Shanghai yuanye Bio-Technology Co., Ltd Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Product Portfolios and Specifications
Table 104. Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 105. Shanghai yuanye Bio-Technology Co., Ltd Main Business
Table 106. Shanghai yuanye Bio-Technology Co., Ltd Latest Developments
Table 107. Chengdu Chaojiuba Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 109. Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 110. Chengdu Chaojiuba Biotechnology Co., Ltd. Main Business
Table 111. Chengdu Chaojiuba Biotechnology Co., Ltd. Latest Developments
Table 112. Nanjing Tianrun Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 114. Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 115. Nanjing Tianrun Biotechnology Co., Ltd. Main Business
Table 116. Nanjing Tianrun Biotechnology Co., Ltd. Latest Developments
Table 1. Notoginsenoside Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Notoginsenoside Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Notoginsenoside R1
Table 4. Major Players of Notoginsenoside R2
Table 5. Global Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 6. Global Notoginsenoside Sales Market Share by Type (2020-2025)
Table 7. Global Notoginsenoside Revenue by Type (2020-2025) & ($ million)
Table 8. Global Notoginsenoside Revenue Market Share by Type (2020-2025)
Table 9. Global Notoginsenoside Sale Price by Type (2020-2025) & (US$/g)
Table 10. Global Notoginsenoside Sale by Application (2020-2025) & (kg)
Table 11. Global Notoginsenoside Sale Market Share by Application (2020-2025)
Table 12. Global Notoginsenoside Revenue by Application (2020-2025) & ($ million)
Table 13. Global Notoginsenoside Revenue Market Share by Application (2020-2025)
Table 14. Global Notoginsenoside Sale Price by Application (2020-2025) & (US$/g)
Table 15. Global Notoginsenoside Sales by Company (2020-2025) & (kg)
Table 16. Global Notoginsenoside Sales Market Share by Company (2020-2025)
Table 17. Global Notoginsenoside Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Notoginsenoside Revenue Market Share by Company (2020-2025)
Table 19. Global Notoginsenoside Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key Manufacturers Notoginsenoside Producing Area Distribution and Sales Area
Table 21. Players Notoginsenoside Products Offered
Table 22. Notoginsenoside Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Notoginsenoside Sales by Geographic Region (2020-2025) & (kg)
Table 26. Global Notoginsenoside Sales Market Share Geographic Region (2020-2025)
Table 27. Global Notoginsenoside Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Notoginsenoside Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Notoginsenoside Sales by Country/Region (2020-2025) & (kg)
Table 30. Global Notoginsenoside Sales Market Share by Country/Region (2020-2025)
Table 31. Global Notoginsenoside Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Notoginsenoside Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 34. Americas Notoginsenoside Sales Market Share by Country (2020-2025)
Table 35. Americas Notoginsenoside Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 37. Americas Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 38. APAC Notoginsenoside Sales by Region (2020-2025) & (kg)
Table 39. APAC Notoginsenoside Sales Market Share by Region (2020-2025)
Table 40. APAC Notoginsenoside Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 42. APAC Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 43. Europe Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 44. Europe Notoginsenoside Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 46. Europe Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 47. Middle East & Africa Notoginsenoside Sales by Country (2020-2025) & (kg)
Table 48. Middle East & Africa Notoginsenoside Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Notoginsenoside Sales by Type (2020-2025) & (kg)
Table 50. Middle East & Africa Notoginsenoside Sales by Application (2020-2025) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Notoginsenoside
Table 52. Key Market Challenges & Risks of Notoginsenoside
Table 53. Key Industry Trends of Notoginsenoside
Table 54. Notoginsenoside Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Notoginsenoside Distributors List
Table 57. Notoginsenoside Customer List
Table 58. Global Notoginsenoside Sales Forecast by Region (2026-2031) & (kg)
Table 59. Global Notoginsenoside Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 61. Americas Notoginsenoside Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Notoginsenoside Sales Forecast by Region (2026-2031) & (kg)
Table 63. APAC Notoginsenoside Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 65. Europe Notoginsenoside Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Notoginsenoside Sales Forecast by Country (2026-2031) & (kg)
Table 67. Middle East & Africa Notoginsenoside Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Notoginsenoside Sales Forecast by Type (2026-2031) & (kg)
Table 69. Global Notoginsenoside Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Notoginsenoside Sales Forecast by Application (2026-2031) & (kg)
Table 71. Global Notoginsenoside Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. ChemFaces Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 73. ChemFaces Notoginsenoside Product Portfolios and Specifications
Table 74. ChemFaces Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. ChemFaces Main Business
Table 76. ChemFaces Latest Developments
Table 77. Merck Group Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Group Notoginsenoside Product Portfolios and Specifications
Table 79. Merck Group Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. Merck Group Main Business
Table 81. Merck Group Latest Developments
Table 82. BioCrick Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 83. BioCrick Notoginsenoside Product Portfolios and Specifications
Table 84. BioCrick Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. BioCrick Main Business
Table 86. BioCrick Latest Developments
Table 87. Yunnan Baiyao Group Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 88. Yunnan Baiyao Group Notoginsenoside Product Portfolios and Specifications
Table 89. Yunnan Baiyao Group Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Yunnan Baiyao Group Main Business
Table 91. Yunnan Baiyao Group Latest Developments
Table 92. Xi'an Tianbao Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 93. Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 94. Xi'an Tianbao Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 95. Xi'an Tianbao Biotechnology Co., Ltd. Main Business
Table 96. Xi'an Tianbao Biotechnology Co., Ltd. Latest Developments
Table 97. Xi'an Zebang Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 98. Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 99. Xi'an Zebang Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 100. Xi'an Zebang Biotechnology Co., Ltd. Main Business
Table 101. Xi'an Zebang Biotechnology Co., Ltd. Latest Developments
Table 102. Shanghai yuanye Bio-Technology Co., Ltd Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Product Portfolios and Specifications
Table 104. Shanghai yuanye Bio-Technology Co., Ltd Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 105. Shanghai yuanye Bio-Technology Co., Ltd Main Business
Table 106. Shanghai yuanye Bio-Technology Co., Ltd Latest Developments
Table 107. Chengdu Chaojiuba Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 109. Chengdu Chaojiuba Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 110. Chengdu Chaojiuba Biotechnology Co., Ltd. Main Business
Table 111. Chengdu Chaojiuba Biotechnology Co., Ltd. Latest Developments
Table 112. Nanjing Tianrun Biotechnology Co., Ltd. Basic Information, Notoginsenoside Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Product Portfolios and Specifications
Table 114. Nanjing Tianrun Biotechnology Co., Ltd. Notoginsenoside Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 115. Nanjing Tianrun Biotechnology Co., Ltd. Main Business
Table 116. Nanjing Tianrun Biotechnology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Notoginsenoside
Figure 2. Notoginsenoside Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Notoginsenoside Sales Growth Rate 2020-2031 (kg)
Figure 7. Global Notoginsenoside Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Notoginsenoside Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Notoginsenoside Sales Market Share by Country/Region (2024)
Figure 10. Notoginsenoside Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Notoginsenoside R1
Figure 12. Product Picture of Notoginsenoside R2
Figure 13. Global Notoginsenoside Sales Market Share by Type in 2025
Figure 14. Global Notoginsenoside Revenue Market Share by Type (2020-2025)
Figure 15. Notoginsenoside Consumed in Medicines
Figure 16. Global Notoginsenoside Market: Medicines (2020-2025) & (kg)
Figure 17. Notoginsenoside Consumed in Health Products
Figure 18. Global Notoginsenoside Market: Health Products (2020-2025) & (kg)
Figure 19. Notoginsenoside Consumed in Others
Figure 20. Global Notoginsenoside Market: Others (2020-2025) & (kg)
Figure 21. Global Notoginsenoside Sale Market Share by Application (2024)
Figure 22. Global Notoginsenoside Revenue Market Share by Application in 2025
Figure 23. Notoginsenoside Sales by Company in 2025 (kg)
Figure 24. Global Notoginsenoside Sales Market Share by Company in 2025
Figure 25. Notoginsenoside Revenue by Company in 2025 ($ millions)
Figure 26. Global Notoginsenoside Revenue Market Share by Company in 2025
Figure 27. Global Notoginsenoside Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Notoginsenoside Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Notoginsenoside Sales 2020-2025 (kg)
Figure 30. Americas Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 31. APAC Notoginsenoside Sales 2020-2025 (kg)
Figure 32. APAC Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 33. Europe Notoginsenoside Sales 2020-2025 (kg)
Figure 34. Europe Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Notoginsenoside Sales 2020-2025 (kg)
Figure 36. Middle East & Africa Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 37. Americas Notoginsenoside Sales Market Share by Country in 2025
Figure 38. Americas Notoginsenoside Revenue Market Share by Country (2020-2025)
Figure 39. Americas Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 40. Americas Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 41. United States Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Notoginsenoside Sales Market Share by Region in 2025
Figure 46. APAC Notoginsenoside Revenue Market Share by Region (2020-2025)
Figure 47. APAC Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 48. APAC Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 49. China Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 53. India Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Notoginsenoside Sales Market Share by Country in 2025
Figure 57. Europe Notoginsenoside Revenue Market Share by Country (2020-2025)
Figure 58. Europe Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 59. Europe Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 60. Germany Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 61. France Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Notoginsenoside Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 68. Egypt Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Notoginsenoside in 2025
Figure 74. Manufacturing Process Analysis of Notoginsenoside
Figure 75. Industry Chain Structure of Notoginsenoside
Figure 76. Channels of Distribution
Figure 77. Global Notoginsenoside Sales Market Forecast by Region (2026-2031)
Figure 78. Global Notoginsenoside Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Notoginsenoside Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Notoginsenoside Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Notoginsenoside Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Notoginsenoside Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Notoginsenoside
Figure 2. Notoginsenoside Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Notoginsenoside Sales Growth Rate 2020-2031 (kg)
Figure 7. Global Notoginsenoside Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Notoginsenoside Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Notoginsenoside Sales Market Share by Country/Region (2024)
Figure 10. Notoginsenoside Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Notoginsenoside R1
Figure 12. Product Picture of Notoginsenoside R2
Figure 13. Global Notoginsenoside Sales Market Share by Type in 2025
Figure 14. Global Notoginsenoside Revenue Market Share by Type (2020-2025)
Figure 15. Notoginsenoside Consumed in Medicines
Figure 16. Global Notoginsenoside Market: Medicines (2020-2025) & (kg)
Figure 17. Notoginsenoside Consumed in Health Products
Figure 18. Global Notoginsenoside Market: Health Products (2020-2025) & (kg)
Figure 19. Notoginsenoside Consumed in Others
Figure 20. Global Notoginsenoside Market: Others (2020-2025) & (kg)
Figure 21. Global Notoginsenoside Sale Market Share by Application (2024)
Figure 22. Global Notoginsenoside Revenue Market Share by Application in 2025
Figure 23. Notoginsenoside Sales by Company in 2025 (kg)
Figure 24. Global Notoginsenoside Sales Market Share by Company in 2025
Figure 25. Notoginsenoside Revenue by Company in 2025 ($ millions)
Figure 26. Global Notoginsenoside Revenue Market Share by Company in 2025
Figure 27. Global Notoginsenoside Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Notoginsenoside Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Notoginsenoside Sales 2020-2025 (kg)
Figure 30. Americas Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 31. APAC Notoginsenoside Sales 2020-2025 (kg)
Figure 32. APAC Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 33. Europe Notoginsenoside Sales 2020-2025 (kg)
Figure 34. Europe Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Notoginsenoside Sales 2020-2025 (kg)
Figure 36. Middle East & Africa Notoginsenoside Revenue 2020-2025 ($ millions)
Figure 37. Americas Notoginsenoside Sales Market Share by Country in 2025
Figure 38. Americas Notoginsenoside Revenue Market Share by Country (2020-2025)
Figure 39. Americas Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 40. Americas Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 41. United States Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Notoginsenoside Sales Market Share by Region in 2025
Figure 46. APAC Notoginsenoside Revenue Market Share by Region (2020-2025)
Figure 47. APAC Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 48. APAC Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 49. China Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 53. India Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Notoginsenoside Sales Market Share by Country in 2025
Figure 57. Europe Notoginsenoside Revenue Market Share by Country (2020-2025)
Figure 58. Europe Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 59. Europe Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 60. Germany Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 61. France Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Notoginsenoside Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Notoginsenoside Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Notoginsenoside Sales Market Share by Application (2020-2025)
Figure 68. Egypt Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Notoginsenoside Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Notoginsenoside in 2025
Figure 74. Manufacturing Process Analysis of Notoginsenoside
Figure 75. Industry Chain Structure of Notoginsenoside
Figure 76. Channels of Distribution
Figure 77. Global Notoginsenoside Sales Market Forecast by Region (2026-2031)
Figure 78. Global Notoginsenoside Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Notoginsenoside Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Notoginsenoside Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Notoginsenoside Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Notoginsenoside Revenue Market Share Forecast by Application (2026-2031)
